Advanced Malignant Neoplasm Recruiting Phase 1 Trials for DB08875 (Cabozantinib)

IndicationStatusPhase
DBCOND0033490 (Advanced Malignant Neoplasm)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01822522Cabozantinib-S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency VirusTreatment